KARACHI, November 5, 2026 — LSE Capital Limited (LSECL) has approved a proposed joint venture with medical and healthcare equipment supplier LABLINK Enterprises to participate in the pre-qualification and bidding process for a project in Sindh.
In a notice submitted to the Pakistan Stock Exchange (PSX) on Thursday, the company said its board had approved the arrangement through a resolution passed by circulation.
LABLINK Enterprises is a registered sole proprietorship involved in importing, distributing and supplying medical, healthcare and surgical products and equipment.
According to the disclosure, the firm deals in products from multinational companies, including NIPRO and Baxter.
Under the proposed arrangement, LSE Capital will partner with LABLINK Enterprises to participate in the project’s pre-qualification and bidding process.
However, LSE Capital did not disclose the project’s nature or estimated value. The notice also provided no details about the joint venture’s financial terms or the responsibilities assigned to each party.
Super Tax: Government Plans Complete Abolition Through Phased Reduction, Says FBR Chief
The disclosure did not confirm whether the proposed partnership had secured pre-qualification or submitted a bid for the project.
The company informed the PSX of the board’s approval for dissemination to market participants.
You may also like
-
Pakistan’s foreign reserves rise to $26.86bn
-
Looming Agricultural Crisis: Delays in Unloading DAP Fertiliser Vessels Threaten Wheat Production and Food Security
-
Gold Prices: Pakistan Rates Jump Rs9,600 to Rs435,636 per Tola
-
Minister Of State Bilal Bin Saqib meets Mastercard’s Division President for East Arabia to discuss Cross-Border payments, Digital-Asset Infrastructure, Tokenisation and Financial-Sector Resilience
-
Pakistan Trade Jam Kamal Holds Bilateral Talks with Saudi Arabia, Egypt and Tunisia
1 thought on “LSE Capital: Company Approves Joint Venture with LABLINK for Sindh Project”
Comments are closed.